Whitehawk Therapeutics (WHWK) Divestments (2025)
Whitehawk Therapeutics (WHWK) posted quarterly Divestments of -$70000.0 for Q3 2025, down 100.07% quarter-over-quarter from $101.4 million in Q1 2025.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Divestments (2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Divestments for 1 consecutive years, with -$70000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Divestments changed N/A year-over-year to -$70000.0; the TTM figure through Mar 2026 stood at -$70000.0 (down 100.07% YoY), while the FY2025 annual figure was $101.3 million, changed N/A from the prior year.
- Divestments retreated to -$70000.0 in Q3 2025 per WHWK's latest filing, from $101.4 million in the prior quarter.
- Across five years, Divestments topped out at $101.4 million in Q1 2025 and bottomed at -$70000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | - |